Table 1. Clinicopathologic findings of rectal cancer patients according to TSR.
| Clinicopathological characteristics | TSR | P value | |
|---|---|---|---|
| Stroma high (n=41) | Stroma low (n=25) | ||
| Male gender, n (%) | 26 (63.4) | 15 (60.0) | 0.781 |
| Age (years) | 61.59±11.25 | 56.36±9.08 | 0.054 |
| TSR scores | 69.51%±12.03% | 26.00%±11.55% | |
| Dominant cell type | 0.304 | ||
| Fibroblast | 38 | 20 | |
| Lymphocyte | 1 | 2 | |
| Collagen | 2 | 3 | |
| LD (cm) | 4.42±1.88 | 3.65±1.31 | 0.074 |
| pT | 0.110 | ||
| T1 | 2 | 3 | |
| T2 | 12 | 10 | |
| T3 | 23 | 11 | |
| T4 | 4 | 1 | |
| pN | 0.853 | ||
| N0 | 26 | 16 | |
| N1 | 10 | 4 | |
| N2 | 5 | 5 | |
| Differentiation grade | 0.405 | ||
| Poorly | 7 | 4 | |
| Moderately | 33 | 18 | |
| Well | 1 | 3 | |
Data given as the mean ± SD. TSR, tumor-stroma ratio; LD, the largest diameter of the tumor; pT, pathological tumor stage; pN, pathological nodal stage; SD, standard deviation.